Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

Not Applicable

Completed

• Conditions: Infection as Complication of Medical Care

• Registration Number: NCT01499927
• Lead Sponsor: University of Zurich

Brief Summary

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Detailed Description

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Study Timeline

• Study First Submitted: 2011-11-15
• Study First Submitted QC: 2011-12-22
• Study First Posted: 2011-12-26
• Study Start: 2012-01
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-18
• Last Update Posted: 2013-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 74766

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
duration of intravenous antiinfective therapy until switching	1 year

Secondary Outcome Measures

Name	Time	Method
costs (per year, per day and patient)	1 year
defined daily doses (per 100 days)	1 year
duration of hospitalization	1 year
ratio of narrow to broad-spectrum antibiotics	1 year
requests for consultations	1 year

Trial Locations

Locations (1)

University Hospital Zurich, Center for Clinical Research; 🇨🇭 Zurich, ZH, Switzerland